Trial Profile
A Multi-Center, Double-Blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Oct 2016
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Registrational; Therapeutic Use
- Sponsors UCB
- 01 Aug 2012 Results published in the Epilepsy Research.
- 22 Sep 2009 Actual patient number (228) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.